Stephanie Okey, Director at Crinetics Pharmaceuticals, sold CRNX on Jun 17, 2026
Prices as of Sep 1 · price update delayed · Every feed →
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CRNX since disclosure
+136.8%
after the sale
Similar stocks (XLV) since disclosure
+14.9%
XLV — its sector index fund
Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Sep 1, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLStephanie Okey DirectorCRNX Crinetics Pharmaceuticals, Inc.$224Kdisclosed Jun 18 · filed 1 day after the trade